Bactericidal activity and postantibiotic effect of clarithromycin and 14-hydroxyclarithromycin, alone and in combination, against Legionella pneumophila

Journal of Antimicrobial Chemotherapy

Volumn 41, Issue 6, 1998, Pages 643-648

  Martin, Steven J ^a   Pendland, Susan L ^b  

^a UNIVERSITY OF TOLEDO   (United States)

^b UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

14 HYDROXYCLARITHROMYCIN; ANTIBIOTIC AGENT; CLARITHROMYCIN;

ARTICLE; BACTERICIDAL ACTIVITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; LEGIONELLA PNEUMOPHILA; NONHUMAN; POSTANTIBIOTIC EFFECT; STRAIN DIFFERENCE;

ANTI-BACTERIAL AGENTS; CLARITHROMYCIN; COLONY COUNT, MICROBIAL; DRUG THERAPY, COMBINATION; LEGIONELLA PNEUMOPHILA; MICROBIAL SENSITIVITY TESTS;

EID: 0031866092     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/41.6.643     Document Type: Article

References (10)

1. Pendland, S. L., Martin, S. J., Chen, C., Schreckenberger, P. & Danziger, L. H. (1994). In vitro activity of clarithromycin and its 14-hydroxy metabolite alone and in combination against 23 clinical isolates of Legionella. In Program and Abstracts of the Second International Conference on the Macrolides, Azalides and Streptogramins, Venice, Italy, 1994. Abstract 138. ICMAS, Altanta, GA.
2. Jones, R. N., Erwin, M. E. & Barrett, M. S. (1990). In vitro activity of clarithromycin (TE-031, A-67268) and 14OH-clarithromycin alone and in combination against Legionella species. European Journal of Clinical Microbiology and Infectious Diseases 9, 846-8.
3. Hardy, D. J., Swanson, R. N., Rode, R. A., Marsh, K., Shipkowitz, N. L. & Clement, J. J. (1990). Enhancement of the in vitro and in vivo activities of clarithromycin against Haemophilus influenzae by 14-hydroxy-clarithromycin, its major metabolite in humans. Antimicrobial Agents and Chemotherapy 34, 1407-13.
4. Hoover, W. W., Barrett, M. S. & Jones, R. N. (1992). Clarithromycin In vitro activity enhanced by its major metabolite, 14-hydroxyclarithromycin. Diagnostic Microbiology and Infectious Disease 15, 259-66.
5. Ristrorph, J. D., Hedlund, K. W. & Allen, R. G. (1980). Liquid medium for growth of Legionella pneumophila. Journal of Clinical Microbiology 11, 19-21.
6. Chu, S. Y., Wilson, D. S., Guay, D. R. & Craft, C. (1992). Clarithromycin pharmacokinetics in healthy young and elderly volunteers. Journal of Clinical Pharmacology 32, 1045-9.
7. Eliopoulos, G. M. & Moellering, R. C. (1996). Antimicrobial combinations. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 330-96. Williams & Wilkins, Baltimore, MD.
8. Craig, W. A. & Gudmundsson, S. (1996). Postantibiotic effect. In Antibiotics in Laboratory Medicine, 4th edn (Lorian, V., Ed.), pp. 296-329. Williams & Wilkins, Baltimore, MD.
9. Neu, H. C. (1991). The development of macrolides: clarithromycin in perspective. Journal of Antimicrobiol Chemotheraphy 27, Suppl. A, 1-9.
10. Contreras, A. & Vazquez, D (1977). Cooperative and antagonistic interactions of peptidyl-tRNA and antibiotics with bacterial ribosomes. European Journal of Biochemistry 74, 539-47.